{
    "2021-08-17": [
        [
            {
                "time": "",
                "original_text": "医药生物行业跨市场周报：国产科研试剂领军企业义翘神州上市 科研服务赛道热度再起",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "科研试剂",
                        "义翘神州",
                        "上市"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药控股子公司注射用曲妥珠单抗获药品补充申请批准通知书",
                "features": {
                    "keywords": [
                        "复星医药",
                        "曲妥珠单抗",
                        "药品批准"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药：阿基仑赛注射液被纳入突破性治疗药物程序",
                "features": {
                    "keywords": [
                        "复星医药",
                        "阿基仑赛",
                        "突破性治疗"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "突然崩了，3800家公司下跌！究竟发生了什么？",
                "features": {
                    "keywords": [
                        "市场下跌",
                        "公司数量",
                        "原因"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "舍得交出复星系入主后首份半年报，下半年这样干！",
                "features": {
                    "keywords": [
                        "舍得",
                        "复星系",
                        "半年报",
                        "下半年计划"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "酒业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周观点：短期回调不改行业高景气发展 关注业绩超预期优质个股投资机会",
                "features": {
                    "keywords": [
                        "医药",
                        "短期回调",
                        "高景气",
                        "投资机会"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【异动股】复星医药(02196.HK)跌3.01%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "股价下跌",
                        "异动"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "智通港股通占比异动统计|8月17日",
                "features": {
                    "keywords": [
                        "港股通",
                        "占比",
                        "异动",
                        "8月17日"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "国内多家企业加速mRNA疫苗研发 疫苗“混打”有效性仍未明确",
                "features": {
                    "keywords": [
                        "mRNA疫苗",
                        "研发",
                        "混打",
                        "有效性"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}